Research uncovers fatal delays in EpiPen treatment for food anaphylaxis in children

Fatal delays in administering life-saving adrenaline autoinjector (EpiPen) for food anaphylaxis, a severe and rapid allergic reaction, are highlighted in research presented at the Royal College of Emergency Medicine Conference. Researchers are urging for updated guidelines on the use of adrenaline treatment such as EpiPens and the hospital management of severe food anaphylaxis.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup